Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
boston top stories
3
×
life sciences
national blog main
cancer
cancer drugs
clinical trials
ipo
national top stories
revolution medicines
san francisco
san francisco blog main
san francisco top stories
sanofi
the column group
third rock ventures
venture capital
warp drive bio
20/20 healthcare partners
amgen
amgen ventures
amyotrophic lateral sclerosis
anthony despasqua
boston
christian angermayer
cobimetinib
colorectal cancer
deals
dolby family ventures
enclear therapies
financing
funding
gf securities
global health sciences fund
hillel bachrach
investing
jason camm
karimah es sabar
labcentral
What
proteins
3
×
cancer
disease
ipo
medicines
research
revolution
associated
cancer’s
companies
despite
develop
device
dialysis
diseases
drug
drugs
enclear
family
frontiers
hardest
harmful
hit
hottest
hunters
known
maps
nets
neuro
neurodegenerative
new
parlance
pharmaceutical
play
raised
ras
reach
reels
revealed
role
Language
unset
Current search:
biotech
×
proteins
×
" boston top stories "
×
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers